Profile
Kent W.
Leyde is the founder of Cadence Neuroscience, Inc. Mr. Leyde is Vice President at Ventec Life Systems, Inc. Mr. Leyde is Advisor at Proxenia Venture Partners LLC.
Mr. Leyde was Principal at HP, Inc. Mr. Leyde was Principal at Heartstream, Inc. Mr. Leyde was Principal at Northstar Neuroscience, Inc. Mr. Leyde was Principal at Physio Control International Corp.
Mr. Leyde was Chief Technology Officer at NeuroVista Corp.
Mr. Leyde completed undergraduate and graduate degrees at Washington State University.
Kent Leyde active positions
| Companies | Position | Start |
|---|---|---|
Cadence Neuroscience, Inc.
Cadence Neuroscience, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Chief Executive Officer | 2016-12-31 |
Proxenia Venture Partners LLC
Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners invests in companies located across the global. The firm targets companies operating in the fields of healthcare, energy, water, agriculture, and sustainability. It provides financing for seed and early stage capital requirements with an investment size of USD 50 - 25 Million. | Consultant / Advisor | - |
Ventec Life Systems, Inc.
Ventec Life Systems, Inc. Medical SpecialtiesHealth Technology Develops medical devices for ventilation therapy | Private Equity Investor | - |
Former positions of Kent Leyde
| Companies | Position | End |
|---|---|---|
| HP INC. | Corporate Officer/Principal | - |
Physio Control International Corp.
Physio Control International Corp. Medical SpecialtiesHealth Technology Manufactures and sells automated external defibrillators for health technology | Corporate Officer/Principal | - |
Northstar Neuroscience, Inc.
Northstar Neuroscience, Inc. Medical SpecialtiesHealth Technology Provides solutions for stroke and other neurological diseases and disorders | Corporate Officer/Principal | - |
Heartstream, Inc.
Heartstream, Inc. Medical SpecialtiesHealth Technology Develops automated external defibrillators | Corporate Officer/Principal | - |
NeuroVista Corp.
NeuroVista Corp. Medical SpecialtiesHealth Technology Manufactures medical devices | Chief Tech/Sci/R&D Officer | - |
Training of Kent Leyde
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
HP, Inc.
HP, Inc. Information Technology ServicesTechnology Services Operates as a technology company that sells laptops, pc desktops, printers and accessories through online | Technology Services |
Heartstream, Inc.
Heartstream, Inc. Medical SpecialtiesHealth Technology Develops automated external defibrillators | Health Technology |
Northstar Neuroscience, Inc.
Northstar Neuroscience, Inc. Medical SpecialtiesHealth Technology Provides solutions for stroke and other neurological diseases and disorders | Health Technology |
Ventec Life Systems, Inc.
Ventec Life Systems, Inc. Medical SpecialtiesHealth Technology Develops medical devices for ventilation therapy | Health Technology |
Physio Control International Corp.
Physio Control International Corp. Medical SpecialtiesHealth Technology Manufactures and sells automated external defibrillators for health technology | Health Technology |
Washington State University
Washington State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NeuroVista Corp.
NeuroVista Corp. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Cadence Neuroscience, Inc.
Cadence Neuroscience, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
Proxenia Venture Partners LLC
Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners invests in companies located across the global. The firm targets companies operating in the fields of healthcare, energy, water, agriculture, and sustainability. It provides financing for seed and early stage capital requirements with an investment size of USD 50 - 25 Million. | Finance |
- Stock Market
- Insiders
- Kent Leyde
















